Aug. 4, 2011 Radient Pharmaceuticals Corporation "the Company" or "Radient" (otcqx:RXPC) (pinksheets:RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has entered into an exclusive distribution agreement with Taiwan-based Uni Pharma, Co. Ltd. Uni Pharma will import, market, and sell Onko-Sure(R) in the Taiwanese market. Onko-Sure(R) is a simple, non-invasive cancer blood test which has received regulatory approval in Taiwan as a general cancer tumor marker. Onko-Sure(R) is also approved as a general cancer tumor marker in several other Asian markets, as well as the European Union. The US FDA has cleared Onko-Sure(R) to market for monitoring colorectal cancer during treatment and for post-treatment recurrence monitoring. Onko-Sure(R) has also received regulatory approval for sale in Canada for lung cancer detection, treatment and recurrence monitoring. "Having already built some traction in the Taiwanese market for Onko-Sure(R), we are pleased to enter into this agreement with a partner like Uni Pharma. They have built well-established distribution and sales channels into doctors' offices, labs, and hospitals," stated Radient's Chairman and CEO, Mr. Douglas MacLellan. Uni Pharma's General Manager, Mr. Terry Lin added, "Onko-Sure(R) is exactly what we were looking for in a high-value cancer diagnostic backed by strong clinical data from different clinical trial sites throughout the world. Our sales team has already received training in the U.S. from Radient's science and marketing executives. We've hired a Product Manager for Onko-Sure(R) who will focus exclusively on the marketing and sale of Onko-Sure(R). We are excited and look forward to a successful launch throughout Taiwan." About Uni Pharma: Founded in 1998, Uni Pharma was established by a group of professional managers with multi-national pharmaceutical company backgrounds and extensive experience in the pharmaceutical industry. Uni Pharma is dedicated to supplying the best products to patients and delivering the most value to its partners. Uni Pharma distributes pharmaceutical and medical device products in Taiwan for nine international firms from seven countries across the globe.
About Radient Pharmaceuticals: Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its FDA-cleared In Vitro Diagnostic Onko-Sure(R) cancer test kit for colorectal cancer treatment and recurrence monitoring. The Company's focus is on the discovery, development and commercialization of unique high-value diagnostic tests that will help physicians answer important clinical questions related to early disease state detection, treatment strategy, and the monitoring of disease progression or recurrence. To learn more about our company, products, and potentially life-saving cancer test, visit www.radient-pharma.com .
No comments:
Post a Comment